PEOPLE ON THE MOVE
Aaron Sato appointed CSO by LakePharma
LakePharma Inc. has elected Aaron Sato to the newly created role of Chief Scientific Officer (CSO).
Belmont, California-based LakePharma is a CRO specializing in antibody engineering, discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing, and bioanalytics.
Prior to LakePharma, he held management positions at Dyax Corp., Oncomed Pharmaceuticals Inc. and Sutro Biopharma Inc., with 40 issued patents in the antibody space.